Value
3.8/10data confidence 50%| Component | Sub-score |
|---|---|
| P/S | 10.0 |
| EV/EBITDA | 0.0 |
| Analyst target | 3.0 |
TDOC · Why this verdict
Why Teladoc Health (TDOC) is rated SELL
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
VerdictSELL
Overall score4.0/10
ConfidenceHIGH
MacroNEUTRAL
TrendMatrix Research · core thesis
Engine thesis — one sentence
Teladoc keeps beating earnings estimates and generates positive free cash flow on a non-GAAP basis, but quality metrics sit right at the engine's minimum threshold and value-trap signals around margin compression argue for caution.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
Thesis pillars
| Pillar | Expectation | Trend |
|---|---|---|
Teladoc's quality score sits right at the engine's floor of 4.0, and the stock shows 2 of 5 value-trap signals including margin compression with an operating margin of -39.8% and negative free cash flow on a GAAP basis. Bear case | The quality score should rise clearly above the 4.0 floor and operating margin should improve toward breakeven over the next 12 months. | ↓Deteriorating |
| CounterThe company is FCF-positive on a non-GAAP basis with an 8% FCF margin and 12.5% FCF yield, suggesting the GAAP operating loss overstates the cash-flow reality. | ||
Teladoc has beaten earnings estimates in all of the last 4 quarters, a perfect beat streak, with an average surprise of 42.55%. Catalyst breakdown | The beat streak should continue at the next report on 2026-07-29. | ↑Improving |
| CounterA perfect beat streak against low guidance can reflect deliberately conservative estimates rather than genuine business acceleration, especially alongside declining revenue. | ||
Revenue is declining at -2% year over year and the company is flagged as having no competitive moat, undercutting the durability of its market position. Growth breakdown | Revenue growth should turn positive, rising above 0%, over the next few quarters. | →Stable |
| CounterEven without a moat, a company can stabilize revenue in a mature but non-shrinking end market, especially with cost discipline improving cash generation. | ||
The stock carries a rich valuation alongside 16% short interest, a combination the engine flags as elevated risk. Key risks | Short interest should decline meaningfully from 16% or the valuation risk flag should clear as the business re-rates toward profitability. | ↓Deteriorating |
| CounterA rich valuation with high short interest can also set up a short squeeze if fundamentals surprise to the upside, independent of the underlying value-trap concerns. | ||
Teladoc's quality score sits right at the engine's floor of 4.0, and the stock shows 2 of 5 value-trap signals including margin compression with an operating margin of -39.8% and negative free cash flow on a GAAP basis.
↓DeterioratingBear case
- Expectation
- The quality score should rise clearly above the 4.0 floor and operating margin should improve toward breakeven over the next 12 months.
CounterThe company is FCF-positive on a non-GAAP basis with an 8% FCF margin and 12.5% FCF yield, suggesting the GAAP operating loss overstates the cash-flow reality.
Teladoc has beaten earnings estimates in all of the last 4 quarters, a perfect beat streak, with an average surprise of 42.55%.
↑ImprovingCatalyst breakdown
- Expectation
- The beat streak should continue at the next report on 2026-07-29.
CounterA perfect beat streak against low guidance can reflect deliberately conservative estimates rather than genuine business acceleration, especially alongside declining revenue.
Revenue is declining at -2% year over year and the company is flagged as having no competitive moat, undercutting the durability of its market position.
→StableGrowth breakdown
- Expectation
- Revenue growth should turn positive, rising above 0%, over the next few quarters.
CounterEven without a moat, a company can stabilize revenue in a mature but non-shrinking end market, especially with cost discipline improving cash generation.
The stock carries a rich valuation alongside 16% short interest, a combination the engine flags as elevated risk.
↓DeterioratingKey risks
- Expectation
- Short interest should decline meaningfully from 16% or the valuation risk flag should clear as the business re-rates toward profitability.
CounterA rich valuation with high short interest can also set up a short squeeze if fundamentals surprise to the upside, independent of the underlying value-trap concerns.
Per-dimension breakdown
Quality
3.1/10data confidence 100%| Component | Sub-score |
|---|---|
| ROE | 0.0 |
| ROA | 0.0 |
| Gross margin | 9.8 |
| Op margin | 0.0 |
| Net margin | 0.0 |
| Current ratio | 3.3 |
| FCF quality | 5.5 |
| Moat | 4.8 |
| Rule of 40 | 3.0 |
| Piotroski F | 4.4 |
- ▸FCF-positive despite GAAP loss (FCF margin 8%, FCF yield 15.3%)
- ▸No competitive moat
- ▸Rule of 40: 4 (fail)
Growth
1.5/10data confidence 33%| Component | Sub-score |
|---|---|
| Rev growth | 1.5 |
- ▸Declining revenue: -4%
Momentum
6.5/10data confidence 100%| Component | Sub-score |
|---|---|
| RSI | 3.7 |
| MACD | 10.0 |
| OBV | 10.0 |
| MA position | 7.5 |
| Volume | 1.1 |
- ▸Overbought (RSI 86)
- ▸Volume accumulation (rising OBV)
- ▸Above 200-MA but MA slope flat/negative + RSI 86 (late-cycle distribution risk)
Sentiment
4.4/10data confidence 100%| Component | Sub-score |
|---|---|
| LLM sentiment | 5.2 |
| Analyst rating | 5.0 |
| Price target | 2.9 |
- ▸Below analyst target
Insider
5.9/10data confidence 100%| Component | Sub-score |
|---|---|
| materiality | 4.5 |
| insider conviction | 2.0 |
| holder change | 10.0 |
| notable moves | 7.0 |
- ▸Modest insider selling — $460,877 (0.037% of mkt cap)
- ▸Institutions accumulating
Peer rank
3.4/10data confidence 80%| Component | Sub-score |
|---|---|
| value rank | 8.6 |
| quality rank | 2.9 |
| growth rank | 0.0 |
Technical
2.8/10data confidence 100%| Component | Sub-score |
|---|---|
| bollinger | 0.0 |
| support resistance | 0.4 |
| 52w position | 7.7 |
| gap | 3.0 |
- ▸Extreme gap up (15.1%) - may pull back
Risk (lower is worse)
3.0/10data confidence 100%| Component | Sub-score |
|---|---|
| short interest | 1.7 |
| days to cover | 1.3 |
| volatility | 0.8 |
| put call | 8.2 |
| implied vol | 0.0 |
| beta | 2.9 |
| debt equity | 6.3 |
- ▸High short interest justified: 18%
- ▸High IV: 90%
Catalyst
8.2/10data confidence 100%| Component | Sub-score |
|---|---|
| erm | 5.0 |
| earnings history | 10.0 |
| surprise avg | 10.0 |
| news activity | 8.0 |
- ▸Perfect beat streak: 4Q
How the verdict was assembled
Engine trigger
Quality below minimum threshold.
Engine technical detail
verdict_path:
L1:HARD_BLOCK:QUALITY_FLOORPassed (7)
- MOMENTUM:6.5>=5.5
- INSIDER:OK
- 8K:CLEAN
- NEWS_BOOST:ANALYST:0.40
- EARNINGS_PROXIMITY:NO_DATE
- SEMI_CYCLE_PEAK:CLEAR
- MATERIALS_CYCLE_PEAK:CLEAR
Failed (1)
- ASYMMETRY:-1.5=NEGATIVE
Warning (1)
- DEATH_CROSS:momentum=6.5>=5.0 recovering
Reward-to-Risk
-1.54
Upside
-23.1%
Downside
15.0%
Sizing output
AVOID
SetupRecovery — Death cross but MACD improving, RSI 86
EdgeNo clear edge — No clear edge identified
SuitabilityAggressive — Beta 2.14>1.3, MCap $1.2B<$5B
Investment implication
The SELL_IF_HOLDING verdict reflects the ASYMMETRY gate's -1.5=NEGATIVE outcome against Catalyst at 8.2 and asymmetric R:R of -1.54.
The strongest dimensions are Catalyst at 8.2, Momentum at 6.5, and Insider at 5.9; the weakest are Growth at 1.5, Technical at 2.8, and Risk (lower is worse) at 3.0. The V9 engine flagged 1 failed gate with 1 warning, producing an asymmetric reward-to-risk of -1.54 and an engine sizing output of AVOID.
What would invalidate the thesis
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1Quality Below Floor Value Trap
Trip ifQuality score rises above 4.0 or operating margin improves above -20% from the current -39.8%.
- P2Perfect Earnings Beat Streak
Trip ifCompany posts a miss with surprise below 0% at the 2026-07-29 report, breaking the beat streak.
- P3Declining Revenue No Moat
Trip ifRevenue growth rises above 3% YoY for 2 consecutive quarters.
- P4Rich Valuation High Short Interest
Trip ifShort interest falls below 8% of float.